Effects of Astaxanthin Supplementation on Lipid Peroxidation

Author:

Karppi 1,Rissanen 2,Nyyssönen 1,Kaikkonen 3,Olsson 4,Voutilainen 1,Salonen 1

Affiliation:

1. Research Institute of Public Health, University of Kuopio, P.O. Box 1627, FI-70211 Kuopio, Finland. Fax: +358 17 162936. E-mail: jouni.karppi@uku.fi, kristiina.nyyssonen@uku.fi, sari.voutilainen@uku.fi

2. The Department of Public Health and Clinical Nutrition, University of Kuopio, P.O. Box 1627, FI-70211 Kuopio, Finland. Fax: +358 17 162937. E-mail: tiina.rissanen@uku.fi.

3. Oy Jurilab Ltd, Microkatu 1, FI-70210 Kuopio, Finland (www.jurilab.com). Fax: +358 17 467 8001. E-mail: jari.kaikkonen@jurilab.com, jukka.salonen@jurilab.com

4. Internal Medicine, Department of Medicine and Care, Berzelius Science Park, University hospital and University of Linköping, SE-58185 Linköping, Sweden. Fax: + 46 13 149991. E-mail: andol@imv.liu.se

Abstract

Astaxanthin, the main carotenoid pigment in aquatic animals, has greater antioxidant activity in vitro (protecting against lipid peroxidation) and a more polar configuration than other carotenoids. We investigated the effect of three-month astaxanthin supplementation on lipid peroxidation in healthy non-smoking Finnish men, aged 19–33 years by using a randomized double-blind study design. Also absorption of astaxanthin from capsules into bloodstream and its safety were evaluated. The intervention group received two 4-mg astaxanthin (Astaxin®) capsules daily, and the control group two identical-looking placebo capsules. Astaxanthin supplementation elevated plasma astaxanthin levels to 0.032 μmol/L (p < 0.001 for the change compared with the placebo group). We observed that levels of plasma 12- and 15-hydroxy fatty acids were reduced statistically significantly in the astaxanthin group (p = 0.048 and p = 0.047 respectively) during supplementation, but not in the placebo group and the change of 15-hydroxy fatty acid was almost significantly greater (p = 0.056) in the astaxanthin group, as compared with the placebo group. The present study suggests that intestinal absorption of astaxanthin delivered as capsules is adequate, and well tolerated. Supplementation with astaxanthin may decrease in vivo oxidation of fatty acids in healthy men.

Publisher

Hogrefe Publishing Group

Subject

Nutrition and Dietetics,General Medicine,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3